Dialysis provider DaVita, El Segundo, Calif., said it agreed to sell 70 dialysis centers for $320.5 million, settling antitrust concerns resulting from its planned acquisition of Gambro Healthcare U.S. RenalAmerica, Nashville, teamed with private equity firm Welsh, Carson, Anderson & Stowe to buy the facilities. DaVita, the nation's second-largest dialysis provider, said it expected to complete its $3.05 billion purchase of Gambro, the third-largest provider, within two months. The company reported second-quarter net income of $52.9 million, or 51 cents per share, up slightly from net income of $52.4 million, or 50 cents per share, in the year-ago quarter. Revenue grew 17.7% to $649 million. In the six months, DaVita earned $109.3 million, or $1.06 per share, compared with $105.3 million, or $1.02 per share, in the year-ago period. Revenue was up 18% to $1.3 billion.
Separately, long-term-care pharmacy Omnicare, Covington, Ky., completed its $1.8 billion purchase of rival NeighborCare, Baltimore, after more than a year of pursuit and the rejection of two previous offers. -- by Joseph Mantone